R&D
AI-based Innovation Discovery Platform
About AZothBio
The Company Specializing in AI-based Discovery of
Innovative Drug Delivery Vehicles and Drug Candidates
PIPELINE
Innovative Treatment
-
01
AZB101 (Autoimmune Disease Therapeutics)
AZB101 is designed to selectively target and inhibit TYK2-JH2, a mechanism linked to numerous autoimmune diseases, such as psoriasis.
-
02
AZB102 (Solid Cancer Therapeutics)
AZB102 is designed to selectively target and inhibit TRKA, a mechanism related to cancers positive for the NTRK fusion gene.
-
03
AZB201 (Nucleic Acid Delivery Vehicle)
AZB201 has the property to form nano-sized particles by combining with nucleic acids and has the function to deliver the nucleic acids to the cell nucleus.
-
04
AZB301 (Tissue Regeneration Therapeutics)
AZB301 is cell-permeable and specifically targets
the endoplasmic reticulum within cells.
